News

Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101

September 26, 2019 12:00 PM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–Curevo, Inc., a Seattle-based biotechnology company invested in by GC Pharma, ...

GC Pharma to Establish Curevo

GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines GC Pharma, IDRI and ...